DALLAS & NORWALK, Conn.--(BUSINESS WIRE)--Signify Health, Inc. a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, today announced the pricing of its initial public offering of 23,500,000 shares of its Class A common stock at a price to the public of $24.00 per share. In addition, the underwriters have a 30-day option to purchase up to an additional 3,525,000 shares of Class A common stock from Signify Health at the initial public offering price less underwriting discounts and commissions.
The shares are expected to begin trading on the New York Stock Exchange (NYSE) on February 11, 2021, under the ticker symbol SGFY. The offering is expected to close on February 16, 2021, subject to customary closing conditions.
The net proceeds from the initial public offering will be used to pay fees and expenses in connection with the offering and the related reorganization transactions and for general corporate purposes, including working capital and potential acquisitions of, or investments in other businesses or technologies that the company believes will complement the current business and expansion efforts.
Goldman Sachs & Co. LLC, J.P. Morgan, Barclays and Deutsche Bank Securities are acting as lead bookrunner agents for the proposed offering. BofA Securities, UBS Investment Bank, Baird, Piper Sandler and William Blair are acting as additional bookrunners.
A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission on February 10, 2021. The offering of these securities is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, collect telephone: 1-212-834-4533, or by emailing at prospectus-eq_fi@jpmchase.com; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at barclaysprospectus@broadridge.com or telephone at 1-888-603-5847; or, Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, New York 10005, or by emailing at prospectus.CPDG@db.com or by calling at (800) 503-4611.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Signify Health
Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Our mission is to transform how care is paid for and delivered so that people can enjoy more healthy, happy days at home. Our solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. Through our platform, we coordinate what we believe is a holistic suite of clinical, social, and behavioral services to address an individual’s healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home.
